This company has been marked as potentially delisted and may not be actively trading. NASDAQ:MDSO Medidata Solutions (MDSO) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Medidata Solutions Stock (NASDAQ:MDSO) 30 days 90 days 365 days Advanced Chart Get Medidata Solutions alerts:Sign Up Key Stats Today's Range$92.21▼$92.2650-Day Range$91.79▼$92.2552-Week Range$60.10▼$98.60Volume7.30 million shsAverage Volume1.24 million shsMarket Capitalization$5.76 billionP/E Ratio96.06Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner support, and e-learning and training. The company markets and sells its cloud-based solutions through a direct sales force and through relationships with channel and strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; academic research centers, government, and other non-profit organizations; and other non-profit organizations; and contract research organizations and other entities engaged in clinical trials. The company was founded in 1999 and is headquartered in New York, New York. Read More Receive MDSO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medidata Solutions and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MDSO Stock News HeadlinesMedidata Secures a Leader Position in Everest Group’s PEAK Matrix® Assessment for eCOA, Driving the New Patient Experience ForwardSeptember 2, 2025 | finance.yahoo.comMedidata Accelerates Business Transformation with Lisa Moneymaker as Chief Strategy OfficerAugust 13, 2025 | finance.yahoo.com2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematically extracting profits from the $4 billion that changes hands in crypto every single day.September 13 at 2:00 AM | Crypto Swap Profits (Ad)Medidata and University of Sydney Partner to Rethink Clinical TrialsJuly 10, 2025 | msn.comNOTICE TO DISREGARD -- Medidata Solutions, Inc.June 3, 2025 | globenewswire.comPharma tech CFO says finance is at the center of AI strategyMay 23, 2025 | fortune.comMDSO announce new non-emergency numberApril 21, 2025 | msn.comMedidata introduces programme to expedite therapy delivery to trial subjectsMarch 28, 2025 | msn.comSee More Headlines MDSO Stock Analysis - Frequently Asked Questions How were Medidata Solutions' earnings last quarter? Medidata Solutions Inc (NASDAQ:MDSO) released its earnings results on Monday, July, 22nd. The company reported $0.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.17 by $0.31. Medidata Solutions's revenue was up 15.8% compared to the same quarter last year. What other stocks do shareholders of Medidata Solutions own? Based on aggregate information from My MarketBeat watchlists, some other companies that Medidata Solutions investors own include Meta Platforms (META), NVIDIA (NVDA), Applied Materials (AMAT), Salesforce (CRM), Gilead Sciences (GILD), Bristol Myers Squibb (BMY) and Allergan (AGN). Company Calendar Last Earnings7/22/2019Today9/13/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Prepackaged Software Sub-IndustryHealth Care Technology Current SymbolNASDAQ:MDSO CIK1453814 Webwww.mdsol.com Phone212-918-1800FaxN/AEmployees1,998Year FoundedN/AProfitability EPS (Trailing Twelve Months)$0.96 Trailing P/E Ratio96.06 Forward P/E Ratio118.23 P/E Growth6.95Net Income$51.92 million Net Margins6.43% Pretax MarginN/A Return on Equity8.64% Return on Assets5.73% Debt Debt-to-Equity Ratio0.27 Current Ratio2.56 Quick Ratio2.56 Sales & Book Value Annual Sales$635.70 million Price / Sales9.06 Cash Flow$1.69 per share Price / Cash Flow54.55 Book Value$10.32 per share Price / Book8.94Miscellaneous Outstanding Shares62,460,000Free FloatN/AMarket Cap$5.76 billion OptionableOptionable Beta1.22 10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (NASDAQ:MDSO) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medidata Solutions Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Medidata Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
